Table 1 Baseline clinical characteristics and laboratory findings in patients with tuberculosis, viral, and bacterial meningitis.
TBM | BM | VM | p value | ||||
|---|---|---|---|---|---|---|---|
n = 295 | n = 130 | n = 4601 | Among three groups | TBM versus BM | BM versus VM | VM versus TBM | |
Age (year), mean ± SD | 44.7 ± 18.6 | 52.1 ± 18.8 | 35.6 ± 14.2 | < 0.001** | < 0.001** | < 0.001** | < 0.001** |
Female, n (%) | 118 (40.0) | 56 (43.1) | 2295 (49.9) | < 0.001** | 0.552 | 0.126 | 0.001** |
Blood | |||||||
Serum WBC, × 103/μL (n) | 9.0 ± 6.1 | 13.2 ± 11.5 | 8.7 ± 4.1 (4538) | < 0.001** | < 0.001** | < 0.001** | 0.728 |
LDH, U/L (n) | 503.8 ± 1078.0 (295) | 460.1 ± 268.2 (125) | 387.2 ± 627.9 (4505) | 0.007** | 0.823 | 0.473 | 0.013* |
Procalcitonin, ng/ml (n) | 3.5 ± 16.2 (122) | 7.1 ± 19.0 (63) | 1.5 ± 9.0 (843) | < 0.001** | 0.404 | 0.056 | 0.360 |
HIV Ag/Ab positive, n (%) | 1 (0.3%) | 0 | 4 (0.1%) | 0.386 | |||
Initial Na level, mmol/L (n) | 136.9 ± 5.9 (295) | 138.3 ± 4.7 (130) | 139.0 ± 3.1 (4537) | < 0.001** | 0.041* | 0.264 | < 0.001** |
Lowest Na level, mmol/L (n) | 131.8 ± 6.4 (295) | 133.1 ± 5.1 (130) | 137.4 ± 3.7 (4537) | < 0.001** | 0.061 | < 0.001** | < 0.001** |
CSF | |||||||
WBC (/μL) | 882.0 ± 7161.1 (285) | 1276.5 ± 2150.7 (112) | 368.5 ± 7797.4 (2797) | 0.279 | 0.786 | < 0.001** | 0.584 |
Neutrophil (%) | 18.9 ± 27.4 | 65.5 ± 31.2 | 15.4 ± 25.6 | < 0.001** | < 0.001** | < 0.001** | 0.198 |
Lymphocyte (%) | 70.8 ± 31.7 | 21.8 ± 26.5 | 52.3 ± 40.1 | < 0.001** | < 0.001** | < 0.001** | < 0.001** |
Eosinophil (%) | 1.0 ± 3.2 | 0.7 ± 1.2 | 1.8 ± 7.3 | 0.427 | 0.817 | 0.027 | 0.305 |
Monocyte (%) | 7.7 ± 11.5 | 7.9 ± 7.9 | 7.8 ± 9.6 | 0.992 | 0.999 | 0.999 | 1.000 |
Glucose, mg/dL (n) | 51.9 ± 23.5 (280) | 55.8 ± 40.9 (105) | 62.2 ± 24.8 (2762) | < 0.001** | 0.363 | 0.114 | < 0.001** |
LDH, U/L (n) | 229.8 ± 1262.9 (272) | 225.0 ± 389.9 (98) | 61.5 ± 249.0 (2706) | < 0.001** | 1.000 | < 0.001** | 0.085 |
Protein, mg/dl (n) | 306.6 ± 795.7 (283) | 240.1 ± 266.9 (112) | 78.8 ± 244.0 (2798) | < 0.001** | 0.516 | < 0.001** | < 0.001** |
CSF tuberculosis culture, positive rate, n (%) | 35/279 (12.5) | 0/61 (0) | 1/1112 (0.1) | ||||
CSF tuberculosis PCR, positive rate, n (%) | 30/262 (11.4) | 0/75 (0) | 1/1515 (0.1) | ||||
Xpert® MTB/RIF, positive rate, n (%) | 29/215 (13.5) | 0/60 (0) | 0/1322 (0) | ||||
CSF VZV PCR, positive rate, n (%) | 2/56 (3.6) | 0/19 (0) | 45/359 (12.5) | ||||
Mortality at 90 days, n (%) | 27 (9.2) | 19 (14.6) | 61 (1.3) | < 0.001** |